Concord Biotech Limited, a, biopharma company, engages in the research and development, manufacture, and sale of pharmaceutical products in India and internationally. It operates through Active Pharmaceutical Ingredients (APIs) and Formulations segments. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, voclosporin, and pimecrolimus for immunosuppressants therapeutic segment; and temsirolimus, everolimus, romidepsin, doxorubicin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment. In addition, the company provides mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, daptomycin, fusidic acid, colistimethate sodium, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi acetate, micafungin sodium, and nystatin for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. Further, the company provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.
Low
987.00
High
1,801.90
Low
1,550.00
High
1,589.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Concord Biotech Limited stacks up against its Biotechnology peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CONCORDBIO Concord Biotech Limited | 1,560.00 | 1.06% | 59.30 | 26.31 | 16,320 | 15.47% | 17.81% | 1,801.90 / 987.00 |
| 2 | ANTHEM ANTHEM BIOSCIENCES LTD | 869.50 | 0.57% | 85.45 | 10.18 | 48,970 | 16.40% | 18.92% | 904.00 / 579.15 |
| 3 | BIOCON Biocon Limited | 413.45 | 0.23% | 122.40 | 3.38 | 67,344 | 3.25% | 3.40% | 447.15 / 337.05 |
| 4 | BLUEJET Blue Jet Healthcare Limited | 595.05 | 0.04% | 43.93 | 13.55 | 11,263 | 1.01% | 41.99% | 784.00 / 325.00 |
| 5 | DCAL Dishman Carbogen Amcis Limited | 173.01 | 0.35% | 167.97 | 1.03 | 2,713 | 11.73% | 34.65% | 321.95 / 128.50 |
| 6 | ONESOURCE ONESOURCE SPECL PHARMA L | 1,532.10 | 0.16% | 0.00 | -4.25 | 17,569 | 8.87% | 23.22% | 1,925.00 / 1,057.00 |
| 7 | PANACEABIO Panacea Biotec Limited | 410.00 | 0.88% | 0.00 | -1.16 | 2,511 | 25.02% | 4.45% | 647.00 / 292.40 |
| 8 | SUPRIYA Supriya Lifescience Limited | 806.20 | 0.68% | 32.71 | 24.65 | 6,489 | 4.70% | 13.27% | 1,085.00 / 545.50 |
| 9 | ZOTA Zota Health Care Limited | 1,087.00 | 0.96% | 0.00 | -31.41 | 3,765 | 23.72% | 10.46% | 1,740.00 / 1,026.20 |